Efficacy of a novel air filtration pillow for avoidance of perennial allergens in symptomatic adults

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 5, 2010, Pages 440-449

  Stillerman, Allan ^a   Nachtsheim, Christopher ^b   Li, William ^b   Albrecht, Mark ^c   Waldman, Joshua ^c  

^a Minneapolis Clinic of Neurology   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PureZone Technologies LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; PERENNIAL ALLERGEN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AIR QUALITY; AIRFLOW; ARTICLE; BREATHING APPARATUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LOCALIZED AIR FILTRATION; MALE; NOSE ALLERGY; PERENNIAL RHINITIS; PILLOW ENCASEMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADULT; ALLERGENS; ANIMALS; BEDDING AND LINENS; CATS; CONJUNCTIVITIS; DOGS; DOUBLE-BLIND METHOD; DUST; ENVIRONMENTAL EXPOSURE; FEMALE; FILTRATION; HUMANS; MALE; MIDDLE AGED; MITES; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 77953174651     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.03.006     Document Type: Article

References (50)

1. Arbes S.J., Cohn R.D., Yin M., et al. House dust mite allergen in US beds: results from the First National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol 111 (2003) 408-414
2. Arbes S.J., Cohn R.D., Yin M., et al. Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: results from the National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol 114 (2004) 111-117
3. Cohn R.D., Arbes S.J., Jaramillo R., Reid L.H., and Zeldin D.C. National prevalence and exposure risk for cockroach allergen in U.S. households. Environ Health Perspect 114 (2006) 522-526
4. Salo P.M., Yin M., Arbes S.J., et al. Dustborne Alternaria alternata antigens in US homes: results from the National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol 116 (2005) 623-629
5. Custovic A. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy 60 (2005) 1112-1115
6. Salo P.M., Arbes S.J., Crockett P.W., et al. Exposure to multiple indoor allergens in US homes and its relationship to asthma. J Allergy Clin Immunol 121 (2008) 678-684
7. Rosenstreich D.L., Eggleston P., Kattan M., et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 336 (1997) 1356-1363
8. Sporik R., Holgate S.T., Platts-Mills T.A., and Cogswell J.J. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood: a prospective study. N Engl J Med 323 (1990) 502-507
9. NHLBI Guidelines for the Diagnosis and Treatment of Asthma. http://www.nhlbi.nih.gov/guidelines/asthma/ Accessed April 21, 2009
10. Wallace D.V., Dykewicz M.S., Bernstein D.I., et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122 suppl (2008) S1-S84
11. Sheikh A., and Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 4 (2001) CD001563
12. Reisman R.E. Do air cleaners make a difference in treating allergic disease in homes?. Ann Allergy Asthma Immunol 87 suppl 3 (2001) 41-43
13. Wood R.A. Air filtration devices in the control of indoor allergens. Curr Allergy Asthma Rep 2 (2002) 397-400
14. McDonald E., Cook D., Newman T., et al. Effect of air filtration systems on asthma: a systematic review of randomized trials. Chest 122 (2002) 1535-1542
15. Björnsdottir U.S., Jakobinudottir S., Runarsdottir V., and Juliusson S. The effect of reducing levels of cat allergen (Fel d 1) on clinical symptoms in patients with cat allergy. Ann Allergy Asthma Immunol 91 (2003) 189-194
16. Morgan W.J., Crain E.F., Gruchalla R.S., et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 351 (2004) 1068-1080
17. Platts-Mills T.A., Vaughan J.W., Carter M.C., and Woodfolk J.A. The role of intervention in established allergy: avoidance of indoor allergens in the treatment of chronic allergic disease. J Allergy Clin Immunol 106 (2000) 787-804
18. Busse P.J., Wang J.J., and Halm E.A. Allergen sensitization evaluation and allergen avoidance education in an inner-city adult cohort with persistent asthma. J Allergy Clin Immunol 116 (2005) 146-152
19. Schönberger H.J.A.M., Maas T., Dompeling E., et al. Compliance of asthmatic families with a primary prevention programme of asthma and effectiveness of measures to reduce inhalant allergens: a randomized trial. Clin Exp Allergy 34 (2004) 1024-1031
20. de Blay F., Fourgaut G., Hedelin G., et al. Medical Indoor Environment Counselor (MIEC): role in compliance with advice on mite allergen avoidance and on mite allergen exposure. Allergy 58 (2003) 27-33
21. Zwemer R.J., and Karibo J. Use of laminar control device as adjunct to standard environmental control measures in symptomatic asthmatic children. Ann Allergy 31 (1973) 284-290
22. Villaveces J.W., Rosengren H., and Evans J. Use of laminar air flow portable filter in asthmatic children. Ann Allergy 38 (1977) 400-404
23. Pedroletti C., Millinger E., Dahlén B., Söderman P., and Zetterström O. Clinical effects of purified air administered to the breathing zone in allergic asthma: a double-blind randomized cross-over trial. Respir Med 103 (2009) 1313-1319
24. Verrall B., Muir D.C., Wilson W.M., et al. Laminar flow air cleaner bed attachment: a controlled trial. Ann Allergy 61 (1988) 117-122
25. Morris R.J., Helm T.J., Schmid W., and Hacker D. A novel air filtration delivery system improves seasonal allergic rhinitis. Allergy Asthma Proc 27 (2006) 63-67
26. Juniper E.F., Rohrbaugh T., and Meltzer E.O. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 111 (2003) 484-490
27. King E., Vailes L.D., Tsay A., Satinover S.M., and Chapman M.D. Simultaneous detection of total and allergen-specific IgE by using purified allergens in a fluorescent multiplex array. J Allergy Clin Immunol 120 (2007) 1126-1131
28. Juniper E.F., Ståhl E., Doty R.L., et al. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 115 suppl 1 (2005) S390-S413
29. Erwin E.A., Woodfolk J.A., Custis N., and Platts-Mills T.A.E. Animal danders. Immunol Allergy Clin North Am 23 (2003) 469-481
30. Storms W.W. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 114 suppl (2004) S146-S153
31. Craig T.J., Teets S., Lehman E.B., Chinchilli V.M., and Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 101 (1998) 633-637
32. Nathan R.A. The burden of allergic rhinitis. Allergy Asthma Proc 28 (2007) 3-9
33. Mintz M., Garcia J., Diener P., et al. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol 92 (2004) 255-261
34. Eggleston P.A. Control of environmental allergens as a therapeutic approach. Immunol Allergy Clin North Am 23 (2003) 533-547 viii-ix
35. Avner D.B., Perzanowski M.S., Platts-Mills T.A., and Woodfolk J.A. Evaluation of different techniques for washing cats: quantitation of allergen removed from the cat and the effect on airborne Fel d 1. J Allergy Clin Immunol 100 (1997) 307-312
36. Wood R.A., Johnson E.F., Van Natta M.L., Chen P.H., and Eggleston P.A. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med 158 (1998) 115-120
37. Terreehorst I., Hak E., Oosting A.J., et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 349 (2003) 237-246
38. Gøtzsche P.C., Johansen H.K., et al. House dust mite control measures for asthma. Cochrane Database Syst Rev 2 (2008) CD001187
39. Nathan R.A., Berger W., Yang W., et al. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol 100 (2008) 497-505
40. Stern M.A., Wade A.G., Ridout S.M., and Cambell L.M. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Ann Allergy Asthma Immunol 81 (1998) 354-358
41. Hughes K., Glass C., Ripchinski M., et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 58 (2003) 380-385
42. Day J., and Carrillo T. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol 102 pt 1 (1998) 902-908
43. Bende M., Carrillo T., Vóna I., da Castel-Branco M.G., and Arheden L. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol 88 (2002) 617-623
44. Davies R. Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis. Clin Drug Investig 16 (1998) 413-420
45. Philip G., Williams-Herman D., Patel P., et al. Efficacy of montelukast for treating perennial allergic rhinitis. Allergy Asthma Proc 28 (2007) 296-304
46. Kim K., Sussman G., Hébert J., et al. Desloratadine therapy for symptoms associated with perennial allergic rhinitis. Ann Allergy Asthma Immunol 96 (2006) 460-465
47. Fantin S., Maspero J., Bisbal C., et al. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Allergy 63 (2008) 924-931
48. Walter Canonica G., Bousquet J., Van Hammée G., et al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med 100 (2006) 1706-1715
49. Mission Allergy product catalog. http://www.missionallergy.com/ Accessed December 15, 2009
50. Garris C., Shah M., D'Souza A., and Stanford R. Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: retrospective cohort analysis of pharmacy claims data. Clin Drug Investig 29 (2009) 515-526